Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Efficacy Study of Interactive Web Application for Problem Solving in Diabetes Management

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Mobile Diabetes Detective (MoDD)

First Posted Date: 2013-12-27

Last Posted Date: 2018-03-15

Lead Sponsor: Columbia University

Target Recruit Count: 248

Registration Number: NCT02021591

Locations: 🇺🇸
Clinical Directors Network, New York, New York, United States

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Phase 2

Completed

Conditions: Alopecia Areata

Interventions: Drug: Abatacept

First Posted Date: 2013-12-23

Last Posted Date: 2019-04-30

Lead Sponsor: Columbia University

Target Recruit Count: 15

Registration Number: NCT02018042

Locations: 🇺🇸
Columbia University Medical Center - Department of Dermatology, New York, New York, United States

Effect of Acid Suppression Medication on Pediatric Microbiome

Not Applicable

Terminated

Conditions: Clostridium Difficile Infection

Interventions: Drug: Omeprazole (suspension)
Other: Lifestyle Modification

First Posted Date: 2013-12-20

Last Posted Date: 2023-12-26

Lead Sponsor: Columbia University

Target Recruit Count: 7

Registration Number: NCT02016820

Locations: 🇺🇸
Morgan Stanley Children's Hospital, New York, New York, United States

Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.

Recruiting

Conditions: Obesity

First Posted Date: 2013-12-02

Last Posted Date: 2023-09-01

Lead Sponsor: Columbia University

Target Recruit Count: 500

Registration Number: NCT01998750

Locations: 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies

Phase 1

Terminated

Conditions: Lymphoid Malignancies
Lymphoma
Hodgkin Lymphoma
Non-hodgkin Lymphoma

Interventions: Drug: RomiDEPsin 10 MG/M2
Drug: Romidepsin 14 MG/M2
Drug: Oral 5-Azacitidine 100 MG
Drug: Oral 5-Azacitidine 200 MG
Drug: Oral 5-Azacitidine 300 MG

First Posted Date: 2013-11-28

Last Posted Date: 2024-08-22

Lead Sponsor: Columbia University

Target Recruit Count: 58

Registration Number: NCT01998035

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Multi-level Determinants of Starting ART Late: Aim 2

Completed

Conditions: Human Immunodeficiency Virus (HIV)
Acquired Immune Deficiency Syndrome (AIDS)

First Posted Date: 2013-11-28

Last Posted Date: 2014-12-16

Lead Sponsor: Columbia University

Target Recruit Count: 136

Registration Number: NCT01997346

Locations: 🇪🇹
Nekemte Hospital, Nekemte, Ethiopia
🇪🇹
Shashemene Hospital, Shashemene, Ethiopia
🇪🇹
Goba Hospital, Goba, Ethiopia

and more 1 locations

Multi-level Determinants of Starting ART Late: Aim 3

Completed

Conditions: Human Immunodeficiency Virus (HIV)
Acquired Immune Deficiency Syndrome (AIDS)

First Posted Date: 2013-11-28

Last Posted Date: 2014-12-16

Lead Sponsor: Columbia University

Target Recruit Count: 1214

Registration Number: NCT01997359

Locations: 🇪🇹
Ambo Hospital, Ambo, Ethiopia
🇪🇹
Bishoftu Hospital, Bishoftu, Ethiopia
🇪🇹
Fitche Hospital, Fitche, Ethiopia

and more 3 locations

Use of Prineo in Breast Reduction Surgery

Not Applicable

Completed

Conditions: Post-operative Scar
Efficiency of Surgical Incision Closure

Interventions: Device: Prineo

First Posted Date: 2013-11-27

Last Posted Date: 2019-05-07

Lead Sponsor: Columbia University

Target Recruit Count: 21

Registration Number: NCT01996917

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Critical Time Intervention-Task Shifting: Randomized Controlled Trial

Not Applicable

Completed

Conditions: Schizophrenia
Psychotic Disorder

Interventions: Behavioral: CTI-TS

First Posted Date: 2013-11-27

Last Posted Date: 2020-06-25

Lead Sponsor: Columbia University

Target Recruit Count: 110

Registration Number: NCT01995864

Locations: 🇨🇱
University of Chile, Santiago, Chile
🇧🇷
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes

Not Applicable

Completed

Conditions: Acute Coronary Syndrome
Depressive Symptoms

Interventions: Other: Cognitive Behavioral Therapy (CBT)
Other: Standard Care
Other: No intervention
Drug: Antidepressant Medication
Other: Depressive symptom screener

First Posted Date: 2013-11-25

Last Posted Date: 2023-04-14

Lead Sponsor: Columbia University

Target Recruit Count: 1501

Registration Number: NCT01993017

Locations: 🇺🇸
Health Partners institute for Research and Education, Bloomington, Minnesota, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸
Duke University, Henderson, North Carolina, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy